Ventricular Septal Defect Clinical Trial
Official title:
Chinese Academy of Medical Sciences, Fuwai Hospital
The purpose of this clinical trial is to verify the safety and effectiveness of the Fully Absorbable VSD Occlusion System and VSD Occlusion System produced by Shanghai shape memory alloy materials co., LTD. Clinical trials are designed as prospective, multicenter, randomized controlled, noninferiority clinical trials. Prospective randomized multicenter trial involving about 108 subjects will be enrolled in 4 centers. Patients will be randomized to two groups in equal proportion (54 in each). The success rate of occlusion at 6 months after operation is the main evaluation index in this clinical trial.
1. This is a prospective, multicenter, randomized and noninferiority clinical trial, which
is designed to compare the effectiveness and safety with the fully absorbable
ventricular septal defect (VSD) occlusion system and VSD occlusion system produced by
Shanghai shape memory alloy materials co., LTD.
2. This trial will recruit about 108 subjects from 4 centers. Patients will be randomized
to two groups in equal proportion (54 in each). The proposal recruiting period is 12
months and the follow-up will be performed at 1 month, 3 months and 6 months after
surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03684161 -
Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
|
||
Completed |
NCT01120964 -
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
|
Phase 1/Phase 2 | |
Completed |
NCT02914652 -
The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
|
Phase 4 | |
Recruiting |
NCT05939713 -
Cera™ VSD Occluder Post Market Clinical Follow-up
|
||
Recruiting |
NCT06298344 -
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
|
Early Phase 1 | |
Recruiting |
NCT05688670 -
Regional Anesthesia Following Pediatric Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02138435 -
Longterm Outcome After Ventricular Septal Defect Closure
|
N/A | |
Recruiting |
NCT05253209 -
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
|
Phase 3 | |
Completed |
NCT00556361 -
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
|
Phase 2 | |
Completed |
NCT05200910 -
The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
|
||
Recruiting |
NCT03127748 -
Cardiac Function After Transcatheter VSD Closure
|
N/A | |
Enrolling by invitation |
NCT06214182 -
Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
|
||
Active, not recruiting |
NCT04667455 -
Improving Care for Children With Congenital Heart Disease.
|
N/A | |
Completed |
NCT04417712 -
Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
|
||
Completed |
NCT01313832 -
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension
|
N/A | |
Active, not recruiting |
NCT04017975 -
Optical Tissue Identification for Myocardial Architecture
|
Phase 2 | |
Completed |
NCT01915277 -
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
|
Phase 1 | |
Completed |
NCT04859036 -
The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters
|